Bladder Cancer
Tailoring Treatment for High-Risk Bladder Cancer: Beyond BCG
February 2nd 2024In an interview with Targeted Oncology, Stephen Williams, MD, discussed a retrospective cohort study analyzing intravesical gemcitabine usage vs Bacillus Calmette-Guérin for the treatment of high-risk non-muscle invasive bladder cancer.
Read More